Rural America's Prescribing Problem

Medicare Part D prescribing looks very different depending on where you live. States with large rural populations consistently show higher opioid prescribing rates, more brand-name drug use, and higher per-patient costs. The urban-rural divide in prescribing isn't just a statistical curiosity — it has real consequences for patient outcomes and taxpayer costs.

The Opioid Geography

The states with the highest average opioid prescribing rates are disproportionately rural:

Why Rural Prescribing Differs

1. Fewer specialists, more generalists — Rural areas rely heavily on Nurse Practitioners and Family Practice providers. These generalists handle a wider range of conditions, including chronic pain, leading to higher opioid prescribing rates.
2. Occupational injuries — Rural economies are dominated by farming, mining, logging, and manufacturing — physically demanding jobs with high injury rates that generate legitimate pain management needs.
3. Pharmacy access — Rural patients often have fewer pharmacy options, potentially limiting access to newer (and sometimes cheaper) medications.
4. Older populations — Rural America skews older. Medicare Part D beneficiaries in rural areas tend to have more chronic conditions requiring more medications.
5. Historical prescribing culture — Some regions developed high-prescribing patterns during the late 1990s/early 2000s opioid expansion and haven't fully corrected.

The Cost Implications

Higher opioid rates don't just affect patient health — they affect taxpayer costs. States with the highest opioid prescribing rates also tend to have higher per-patient drug costs, partly because opioid-heavy practices often coincide with:

• More brand-name prescribing (less access to generic alternatives)
• Higher emergency utilization from drug interactions and overdoses
• Longer treatment durations and dose escalation

Small States, Big Problems

States with fewer than 10,000 Medicare Part D prescribers — typically smaller, more rural states — tell a compelling story. Of the 16 states in this category, the average opioid prescribing rate is 14.1%, compared to the national average of 0.0%.

The Specialist Desert

Rural areas face a critical shortage of specialists — pain management doctors, addiction medicine specialists, and psychiatrists are concentrated in urban centers. When a patient in rural West Virginia needs chronic pain treatment, they're far more likely to see a Family Practice provider than a dedicated pain management specialist.

This matters because our peer comparison data shows that generalists who manage pain have different prescribing patterns than dedicated pain specialists. A Family Practice doctor with a 15% opioid rate stands out among their peers, but a Pain Management specialist at 45% is within normal range for their specialty.

The result: rural providers face pressure to treat conditions they weren't specifically trained for, with fewer consultation options and less access to alternative treatments like physical therapy or cognitive behavioral therapy.

Five-Year Trends: Is It Getting Better?

Nationally, opioid prescribing has been declining since 2019, driven by CDC guidelines, state prescription monitoring programs (PDMPs), and increased awareness. But the rural-urban gap persists. States that started with the highest rates have reduced prescribing, but they started from such elevated baselines that they still lead nationally.

Colorado consistently shows among the highest state-level opioid rates — but this is partly a data artifact. Colorado has aggressive prescription monitoring, which means more opioid prescriptions are captured in the data rather than diverted off-record. States with less monitoring may undercount.

Policy Implications

The rural prescribing gap isn't primarily a fraud problem — it's a healthcare access problem wearing a prescribing costume. Addressing it requires:

• Telehealth expansion — Our telehealth analysis shows that remote consultations can connect rural patients with specialists without requiring travel
• Pain management alternatives — Physical therapy, acupuncture, and non-opioid medications need to be as accessible in rural Appalachia as in suburban Virginia
• Provider education — Continuing education requirements should address rural-specific prescribing challenges
• Data transparency — Tools like OpenPrescriber make geographic prescribing patterns visible, enabling targeted interventions rather than one-size-fits-all policies

What the Data Can't Tell Us

Medicare Part D data captures prescribing patterns but not patient outcomes. A high opioid rate might reflect appropriate care for a patient population with high injury rates — or it might reflect over-prescribing. Without linking to patient outcomes data (emergency visits, overdose rates, mortality), we can't definitively distinguish between the two.

What we can say is that the geographic variation is persistent and significant — the same states led in opioid prescribing five years ago and still lead today. Whatever is driving these patterns isn't going away on its own.